药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Forasartan
Abetimus
The risk or severity of adverse effects can be increased when Abetimus is combined with Idelalisib.
Forasartan
Mepolizumab
The risk or severity of adverse effects can be increased when Mepolizumab is combined with Idelalisib.
Forasartan
Human interferon omega-1
The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Idelalisib.
Forasartan
Briakinumab
The risk or severity of adverse effects can be increased when Briakinumab is combined with Idelalisib.
Forasartan
Glatiramer
The risk or severity of adverse effects can be increased when Glatiramer is combined with Idelalisib.
Forasartan
Interferon alfa
The risk or severity of adverse effects can be increased when Interferon alfa is combined with Idelalisib.
Forasartan
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Idelalisib.
Forasartan
Brequinar
The risk or severity of adverse effects can be increased when Brequinar is combined with Idelalisib.
Forasartan
2-Methoxyethanol
The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Idelalisib.
Forasartan
Vorinostat
The risk or severity of adverse effects can be increased when Vorinostat is combined with Idelalisib.
Forasartan
Castanospermine
The risk or severity of adverse effects can be increased when Castanospermine is combined with Idelalisib.
Forasartan
Stepronin
The risk or severity of adverse effects can be increased when Stepronin is combined with Idelalisib.
Forasartan
Ciclesonide
The risk or severity of adverse effects can be increased when Ciclesonide is combined with Idelalisib.
Forasartan
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Idelalisib.
Dihydroquinidine barbiturate
Relugolix
The serum concentration of Relugolix can be increased when it is combined with Netupitant.
Dihydroquinidine barbiturate
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Netupitant.
Dihydroquinidine barbiturate
Pralsetinib
The serum concentration of Pralsetinib can be increased when it is combined with Netupitant.
Dihydroquinidine barbiturate
Satralizumab
The serum concentration of Netupitant can be decreased when it is combined with Satralizumab.
Dihydroquinidine barbiturate
Oliceridine
The serum concentration of Oliceridine can be increased when it is combined with Netupitant.
Dihydroquinidine barbiturate
Abametapir
The serum concentration of Netupitant can be increased when it is combined with Abametapir.